Food News and Research

RSS

Study highlights benefits of reducing dietary salt

"This study provides excellent ammunition both to convince patients about the benefits of reducing their individual salt intakes and also to persuade the EU of the urgent need to introduce legislation to restrict the salt content of processed foods," said ESC spokesman Professor Frank Ruschitzka, a cardiologist and hypertension specialist from the University of Zurich, Switzerland.

28 Jan 2010

Scientific and regulatory experts to discuss global and domestic public health issues

The United States Pharmacopeial Convention (USP) will convene a meeting of its member organizations on April 21󈞄 in Washington, D.C. Member delegates and experts from around the world will gather to discuss pressing global and domestic public health issues.

28 Jan 2010

Real-time data provide baseline information on sodium contents of processed foods

Sodium is essential for myriad biological processes including fluid balance and muscle contraction. However, too much sodium can have harmful effects such as increasing blood pressure.

28 Jan 2010

Researchers design smart capsules that release their contents on demand

How can an active principle be delivered in a controlled way? Until now, there was no obvious answer to this question. Now however, researchers at the CNRS Paul Pascal Research Center in Bordeaux have designed smart capsules that are able to release their contents on demand, simply by raising the temperature. Described in an article published on 2 February 2010 in the journal Langmuir, this novel system has just been patented. It opens up the way to many applications in a large number of fields such as food, perfumes and agriculture, for instance to deliver pesticides above a specific temperature.

28 Jan 2010

Onset Therapeutics expands its sales force to create nationwide presence

Onset Therapeutics LLC, a specialty pharmaceutical company focused in dermatology, today announced that the Company’s recent growth and future opportunities have facilitated an expansion of its field sales organization to cover more than twenty-five additional major metropolitan areas.

28 Jan 2010

Pfizer's new pipeline shows growth and diversity in research and development

Pfizer Inc. today provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October, 2009. The new development pipeline, composed of assets from both legacy companies, includes 133 programs from phase 1 through registration, and shows growth and increased diversity in each of the areas where the company invests in research and development.

28 Jan 2010

Health education programmes can help parents recognise healthy weight for their children

Half of the mothers who took part in a study thought that their obese four or five year-old was normal weight, as did 39 per cent of the fathers, according to the February issue of Acta Paediatrica.

28 Jan 2010

New scientific data reveals wood pallets present dangerous risks to our foods and medicines

Coming on the heels of the sweeping Tylenol recall, new scientific data from independent tests reveal more about the hidden dangers of wood pallets and the threat they pose to the foods we eat and the medications we rely on every day.

28 Jan 2010

Braces and supports can help prevent injury while gardening

Women risk any number of strains, sprains, and injuries while working in their gardens, but by using braces designed specifically for women’s bodies such as the ones made by Wellgate for Women, women are able to help reduce their pain and support their joints while still enjoying all the peace and relaxation that a garden brings.

28 Jan 2010

Public health officials investigate multistate outbreak of Salmonella Montevideo

The Centers for Disease Control and Prevention, the U.S. Food and Drug Administration and the U.S. Department of Agriculture's Food Safety and Inspection Service are investigating a multistate outbreak of Salmonella Montevideo.

28 Jan 2010

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.

28 Jan 2010

Indoor tanning: FTC prohibits ITA from making false health and safety claims

The American Academy of Dermatology (Academy) applauds the Federal Trade Commission (FTC) for issuing a consent order that prohibits the Indoor Tanning Association (ITA) from making false health and safety claims about indoor tanning. The Academy raised its concerns about the false statements being made by the ITA with the FTC in 2008 after the ITA launched an advertising campaign designed to portray indoor tanning as safe and beneficial.

28 Jan 2010

Researchers use nanofactories to prevent bacteria without using antibiotics

New research at the A. James Clark School of Engineering could prevent bacterial infections using tiny biochemical machines—nanofactories—that can confuse bacteria and stop them from spreading, without the use of antibiotics.

28 Jan 2010

Seroquel XR's FDA approval does not change Decision Resources' earlier antipsychotics market forecast

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the recent decision by the U.S. Food and Drug Administration (FDA) to grant approval of AstraZeneca's Seroquel XR for adjunctive treatment of major depressive disorder will not change Decision Resources' market forecast for the indication. As previously forecasted, Seroquel and Seroquel XR will garner nearly one quarter of antipsychotics sales as adjunctive treatments for major depressive disorder in 2013 in the world's major pharmaceutical markets.

28 Jan 2010

Yeast could help prevent sale of aflatoxin-contaminated food

Pistachios, almonds and other popular tree nuts might someday be routinely sprayed with a yeast called Pichia anomala. Laboratory and field studies by Agricultural Research Service (ARS) plant physiologist Sui-Sheng (Sylvia) Hua have shown that the yeast competes successfully for nutrients--and space to grow--that might otherwise be used by an unwanted mold, Aspergillus flavus.

28 Jan 2010

Over 8% of medical devices in circulation are counterfeit: WHO

Counterfeit medical products are becoming an international epidemic. According to the World Health Organization (WHO), more than 8% of the medical devices in circulation are counterfeit. The offending products may be assembled from inferior quality components, or worse yet, from fake parts that could contain toxic materials. In either case the dangers are the same. Counterfeit medical devices pose a significant liability to the manufacturers and a health risk to both the patients and healthcare providers that could result in injury, permanent disability, or even death.

28 Jan 2010

Sepracor's STEDESA NDA: FDA extends PDUFA action date

Sepracor Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010.

28 Jan 2010

BG Medicine launches new, CE-marked galectin-3 test

BG Medicine, Inc., a privately-held developer of biomarker-based in vitro diagnostics, today announced the commercial launch in the European Union of a new, CE-marked test for the measurement of galectin-3 in human plasma or serum. Galectin-3 was first shown by researchers at the University of Maastricht, The Netherlands, to play an integral role in the development and progression of heart failure.

27 Jan 2010

Large research gap exists in effectiveness, mechanism and safety of drugs in children

Only a few anti-spasticity medications used for children with cerebral palsy are backed by sufficient research to justify their use, according to a new review of scientific literature headed by a UT Southwestern Medical Center neurologist and conducted by a national panel of interdisciplinary experts nationwide.

27 Jan 2010

Gilead Sciences reviewing Notice Letter regarding Teva Pharmaceuticals' generic Viread ANDA

Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Viread® (tenofovir disoproxil fumarate).

27 Jan 2010

Food News and Research

Study highlights benefits of reducing dietary salt

Scientific and regulatory experts to discuss global and domestic public health issues

Real-time data provide baseline information on sodium contents of processed foods

Researchers design smart capsules that release their contents on demand

Onset Therapeutics expands its sales force to create nationwide presence

Pfizer's new pipeline shows growth and diversity in research and development

Health education programmes can help parents recognise healthy weight for their children

New scientific data reveals wood pallets present dangerous risks to our foods and medicines

Braces and supports can help prevent injury while gardening

Public health officials investigate multistate outbreak of Salmonella Montevideo

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Indoor tanning: FTC prohibits ITA from making false health and safety claims

Researchers use nanofactories to prevent bacteria without using antibiotics

Seroquel XR's FDA approval does not change Decision Resources' earlier antipsychotics market forecast

Yeast could help prevent sale of aflatoxin-contaminated food

Over 8% of medical devices in circulation are counterfeit: WHO

Sepracor's STEDESA NDA: FDA extends PDUFA action date

BG Medicine launches new, CE-marked galectin-3 test

Large research gap exists in effectiveness, mechanism and safety of drugs in children

Gilead Sciences reviewing Notice Letter regarding Teva Pharmaceuticals' generic Viread ANDA

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News